Updated Jul 16, 2026 · Last SEC filing 2026-06-15
Elevance Health, Inc. (ELV) has filed 13 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-15. 4 Form 8-K material event filings were reported by ELV in the last 90 days. 4 Form 144 notices of proposed sale were filed for ELV stock. InsiderAlpha tracks every ELV SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Hospital & Medical Service Plans (SIC 6324) |
|---|---|
| SEC CIK | 0001156039 |
| Form 4 filings (90d) | 13 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Form 144 notices (90d) | 4 |
| Latest Form 4 filing | 2026-06-15 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Penczek Ronald W | CAO & Controller | S — Open-market sale | 369 | $403.16 | $149K | SEC | |
| Dixon Robert L JR | Director | S — Open-market sale | 151 | $401.77 | $61K | SEC | |
| Penczek Ronald W | CAO & Controller | M — Option exercise | 877 | $311.48 | $273K | SEC | |
| Penczek Ronald W | CAO & Controller | S — Open-market sale | 1.5K | $403.13 | $617K | SEC | |
| Penczek Ronald W | CAO & Controller | M — Option exercise | 654 | $271.27 | $177K | SEC | |
| Neri Antonio F | Director | A — Grant or award | 563 | $0.00 | — | SEC | |
| Jallal Bahija | Director | A — Grant or award | 563 | $0.00 | — | SEC | |
| STRABLE-SOETHOUT DEANNA D | Director | A — Grant or award | 563 | $0.00 | — | SEC | |
| COLLIS STEVEN H | Director | A — Grant or award | 563 | $0.00 | — | SEC | |
| SCHULMAN AMY W | Director | A — Grant or award | 563 | $0.00 | — | SEC | |
| Schneider Ryan M. | Director | A — Grant or award | 563 | $0.00 | — | SEC | |
| PERU RAMIRO G | Director | A — Grant or award | 563 | $0.00 | — | SEC | |
| Dixon Robert L JR | Director | A — Grant or award | 563 | $0.00 | — | SEC | |
| HAY LEWIS III | Director | A — Grant or award | 563 | $0.00 | — | SEC | |
| DeVore Susan D. | Director | A — Grant or award | 563 | $0.00 | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Elevance Health, Inc. (ELV). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Penczek Ronald W | 6 | $1.22M |
| Dixon Robert L JR | 2 | $61K |
| DeVore Susan D. | 1 | — |
| Neri Antonio F | 1 | — |
| COLLIS STEVEN H | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ELV insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live ELV dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.